Hengrui Pharma and Braveheart Bio Announce Positiv...
Category : Clinical Trial Update 12 May 2026"Results with next-generation cardiac myosin inhibitor suggest a potentially disease-modifying...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
MetaVia to Present Data Highlighting DA-1726, a GL...
Category : Clinical Trial Update 12 May 2026"MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming ca...
Myrtelle to Present Clinical Data and Regulatory P...
Category : Clinical Trial Update 12 May 2026"Myrtelle, Inc., a clinical-stage gene therapy company selected by the FDA for the START Pilot...
PulseSight Reports Positive Phase 1 Results for PS...
Category : Clinical Trial Update 11 May 2026PulseSight Therapeutics SAS has reported encouraging Phase 1 clinical trial results for PST-611 in p...
Longeveron Faces Regulatory Setback in HLHS Cell T...
Category : Clinical Trial Update 11 May 2026Longeveron Inc. has shared details from a recent Type C meeting with the U.S. Food and Drug Administ...
Latest Newsletter Post
-
Myrtelle to Present Clinical Data a..
12 May 2026
-
MetaVia to Present Data Highlightin..
12 May 2026
-
Hengrui Pharma and Braveheart Bio A..
12 May 2026
-
WhiteSwell Reports Encouraging DELT..
11 May 2026
-
Longeveron Faces Regulatory Setback..
11 May 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com